John C Reed Johnson & Johnson (JNJ) insider trading activity
John C Reed is EVP, Innovative Medicine, R&D of JOHNSON & JOHNSON. Currently has a direct ownership of 29,795 shares of JNJ, which is worth approximately $4.63 Million. The most recent transaction as insider was on May 01, 2025, when has been sold 11,002 shares (Common Stock) at a price of $156.31 per share, resulting in proceeds of $1,719,722. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
29.8K
91.71%
3M change
157.36%
12M change
Total Value Held
$4.63 Million
JOHN C REED Transaction History
JCR
John C Reed
EVP, Innovative Medicine, R&D
New Brunswick, NJ